scholarly journals Latex glove use among healthcare workers in Australia

2018 ◽  
Vol 46 (9) ◽  
pp. 1014-1018 ◽  
Author(s):  
Renee N. Carey ◽  
Lin Fritschi ◽  
Timothy R. Driscoll ◽  
Michael J. Abramson ◽  
Deborah C. Glass ◽  
...  
2021 ◽  
Vol 108 (Supplement_6) ◽  
Author(s):  
A Zargaran ◽  
D Zargaran ◽  
M Ashraf ◽  
P Khanal ◽  
A Srivastava ◽  
...  

Abstract Introduction Natural Rubber Latex (NRL) gloves have been ubiquitously used in surgical practice. Over the past few decades, there have been many reports of NRL allergies associated with their use presenting a safety hazard to both patients and healthcare workers. Powder-free and latex-free gloves have been shown to offer reductions in incidence of allergic reactions, as well as cost savings. Method We performed a literature search to identify the rates of reaction to latex across the population in addition to the associated costs including litigation costs, costs of admission, and lost work time associated. We further looked at the rates of perforation of alternatives and the costs associated with such a transition. Results The UK prevalence of sensitisation amongst healthcare workers has been estimated to be 10%. The average cost of litigation to the employer was found to be $21,402 per claim. The mean cost of inpatient care for anaphylaxis has been cited as £469.88, with additional costs such as follow-up representing approximately £400. A 14-month study found cost savings of $10,000pa with a switch to non-latex gloves. Furthermore, an overall perforation rate of 80% in a latex-free glove compared to 34.4% in a latex glove. Conclusions From a business perspective, there is evidence of cost-savings arising from a switch to latex-free gloves, however, formal cost-effectiveness analyses would inform future decisions. Furthermore, comfort and reducing the chances of allergic reactions through removing the offending allergen all represent benefits of switching to latex-free gloves, however, non-inferiority analyses will inform future strategies both locally and nationally.


In the healthcare environment, medical latex gloves are a necessary medical item for healthcare workers as it offers excellent hand barrier protection against dangerous microorganism. However, if the healthcare workers repeated exposure to the latex gloves which contain high protein level, it will increase the possibility of the workers to have a risk for latex allergy. Thus, the objective of this project is to develop a color kernel regression (CKR) method for estimating protein level through the analyses of color difference in glove images. Initially, the gloves will go through an uncomplicated chemical test for protein detection. A blue color will appear on the surface of a glove sample that contains protein. After that, the chemical binded sample will be digitally converted into a sample image using the flatbed scanner. The image will then undergo image processing to improve its quality and to calculate the color difference values of the sample. Those calculated values with the pre-defined protein levels will be used to plot a standard graph. A high coefficient of determination with R2 > 98% has been obtained from the experimental graph. This indicates that the proposed CKR method contributes significantly toward the estimation of protein level


2011 ◽  
Vol 32 (12) ◽  
pp. 1194-1199 ◽  
Author(s):  
Christopher Fuller ◽  
Joanne Savage ◽  
Sarah Besser ◽  
Andrew Hayward ◽  
Barry Cookson ◽  
...  

Background and Objective.Wearing of gloves reduces transmission of organisms by healthcare workers' hands but is not a substitute for hand hygiene. Results of previous studies have varied as to whether hand hygiene is worse when gloves are worn. Most studies have been small and used nonstandardized assessments of glove use and hand hygiene. We sought to observe whether gloves were worn when appropriate and whether hand hygiene compliance differed when gloves were worn.Design.Observational study.Participants and Setting.Healthcare workers in 56 medical or care of the elderly wards and intensive care units in 15 hospitals across England and Wales.Methods.We observed hand hygiene and glove usage (7,578 moments for hand hygiene) during 249 one-hour sessions. Observers also recorded whether gloves were or were not worn for individual contacts.Results.Gloves were used in 1,983 (26.2%) of the 7,578 moments for hand hygiene and in 551 (16.7%) of 3,292 low-risk contacts; gloves were not used in 141 (21.1%) of 669 high-risk contacts. The rate of hand hygiene compliance with glove use was 41.4% (415 of 1,002 moments), and the rate without glove use was 50.0% (1,344 of 2,686 moments). After adjusting for ward, healthcare worker type, contact risk level, and whether the hand hygiene opportunity occurred before or after a patient contact, glove use was strongly associated with lower levels of hand hygiene (adjusted odds ratio, 0.65 [95% confidence interval, 0.54-0.79]; P<.0001).Conclusion.The rate of glove usage is lower than previously reported. Gloves are often worn when not indicated and vice versa. The rate of compliance with hand hygiene was significantly lower when gloves were worn. Hand hygiene campaigns should consider placing greater emphasis on the World Health Organization indications for gloving and associated hand hygiene.Trial Registration.National Research Register N0256159318.


1999 ◽  
Author(s):  
J. Antonio Escamilla-Cejudo ◽  
Christine D. Karkashian ◽  
Robyn R. M. Gershon ◽  
Larry Murphy

2019 ◽  
Author(s):  
José Antonio Ruiz-Hernández ◽  
María Sánchez-Muñoz ◽  
José Antonio Jiménez- Barbero ◽  
David Pina López ◽  
Inmaculada Galían-Muñoz ◽  
...  

2012 ◽  
Vol 3 (1) ◽  
pp. 65-67
Author(s):  
Mehmet Karatas ◽  
◽  
Yusuf Yakupogullari ◽  
Mehmet Fatih Korkmaz ◽  
Leyla Kilic ◽  
...  
Keyword(s):  

2018 ◽  
Vol 2 (1) ◽  
pp. 49
Author(s):  
Enis Uruci

Exposure prevention is the primary strategy to reduce the risk of occupational bloodborne pathogen infections in healthcare workers (HCW). HCWs should be made aware of the medicolegal and clinical relevance of reporting an exposure, and have ready access to expert consultants to receive appropriate counselling, treatment and follow-up. Vaccination against hepatitis B virus (HBV), and demonstration of immunisation before employment are strongly recommended. HCWs with postvaccinal anti-HBs levels, 1-2 months after vaccine completion, .or=10 mIU/mL are considered as responders. Responders are protected against HBV infection: booster doses of vaccine or periodic antibody concentration testing are not recommended. Alternative strategies to overcome non-response should be adopted. Isolated anti-HBc positive HCWs should be tested for anti-HBcIgM and HBV-DNA: if negative, anti-HBs response to vaccination can distinguish between infection (anti-HBs .or=50 mIU/ml 30 days after 1st vaccination: anamnestic response) and false positive results(anti-HBs .or=10 mUI/ml 30 days after 3rd vaccination: primary response); true positive subjects have resistance to re-infection. and do not need vaccination The management of an occupational exposure to HBV differs according to the susceptibility of the exposed HCW and the serostatus of the source. When indicated, post-exposure prophylaxis with HBV vaccine, hepatitis B immunoglobulin or both must be started as soon as possible (within 1-7 days). In the absence of prophylaxis against hepatitis C virus (HCV) infection, follow-up management of HCV exposures depends on whether antiviral treatment during the acute phase is chosen. Test the HCW for HCV-Ab at baseline and after 6 months; up to 12 for HIV-HCV co-infected sources. If treatment is recommended, perform ALT (amino alanine transferase) activity at baseline and monthly for 4 months after exposure, and qualitative HCV-RNA when an increase is detected. Introduction Bloodborne pathogens such as hepatitis B (HBV) and C virus (HCV) represent an important hazard for healthcare workers (HCWs) (1). In the general population, HCV prevalence varies geographically from about 0.5% in northern countries to 2% in Mediterranean countries, with some 5 million chronic carriers estimated in Europe; while HBV prevalence ranges from 0.3% to 3%. The World Health Organization (WHO) estimates that each year in Europe 304 000 HCWs are exposed to at least one percutaneous injury with a sharp object contaminated with HBV, 149 000 are exposed to HCV and 22 000 to HIV. The probability of acquiring a bloodborne infection following an occupational exposure has been estimated to be on average.


Sign in / Sign up

Export Citation Format

Share Document